Dr. Adele Hosseini, Chief Scientific Officer at Bod Australia, has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues to development of new strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit.